New study aims to improve prostate cancer diagnosis in african american and white men
NCT ID NCT03234556
First seen Jan 07, 2026 · Last updated Jun 16, 2026 · Updated 23 times
Summary
This study compares two biopsy methods—standard random biopsy and MRI-guided fusion biopsy—to see which better detects significant prostate cancer in African American and white men with elevated PSA levels. About 288 men will participate. The goal is to improve accuracy and reduce unnecessary procedures.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH STATUS UNKNOWN are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Henry Ford Hospital Vattikuti Urology Institute
Detroit, Michigan, 48202, United States
-
Memorial Sloan-Kettering Cancer Center
New York, New York, 10065, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Maryland
Baltimore, Maryland, 21201, United States
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.